<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">INI</journal-id>
<journal-id journal-id-type="hwp">spini</journal-id>
<journal-id journal-id-type="nlm-ta">Innate Immun</journal-id>
<journal-title>Innate Immunity</journal-title>
<issn pub-type="ppub">1753-4259</issn>
<issn pub-type="epub">1753-4267</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1753425912455675</article-id>
<article-id pub-id-type="publisher-id">10.1177_1753425912455675</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Polymorphisms and expression of <italic>TLR4</italic> and <italic>9</italic> in malaria in two ethnic groups of Assam, northeast India</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sawian</surname><given-names>Clara E</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Lourembam</surname><given-names>Sonia D</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Banerjee</surname><given-names>Arunabha</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Baruah</surname><given-names>Shashi</given-names></name>
<xref ref-type="corresp" rid="corresp1-1753425912455675"/>
</contrib>
<aff id="aff1-1753425912455675">Department of Molecular Biology and Biotechnology, Tezpur University, India</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1753425912455675">Shashi Baruah, Molecular Biology and Biotechnology Department, Tezpur University, Tezpur-784028, Assam, India. Email: <email>sbaruah@tezu.ernet.in</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>174</fpage>
<lpage>183</lpage>
<history>
<date date-type="received"><day>19</day><month>3</month><year>2012</year></date>
<date date-type="rev-recd"><day>29</day><month>5</month><year>2012</year></date>
<date date-type="rev-recd"><day>18</day><month>6</month><year>2012</year></date>
<date date-type="accepted"><day>24</day><month>6</month><year>2012</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Infectious diseases have been postulated to play an important role in exerting pressure and in selection of TLR polymorphisms. Single nucelotide polymorphisms (SNPs) of <italic>TLR4</italic> have been reported to show unique distributions in populations from Africa, Asia and Europe, and malaria is suggested to influence these patterns. In this context, we examined association of TLR polymorphisms with the risk of malaria in two ethnic groups—the Austro-Asiatics and Tibeto-Burmans—from malaria endemic districts of Assam to understand the influence of malaria in selection of TLRs in these genetically-distinct populations. <italic>TLR9</italic> (T-1237C) mutation was positively associated with complicated (<italic>P</italic> = 0.001) and frequent (<italic>P</italic> = 0.035) malaria in Austro-Asiatics (relative risk = 0.595 95% CI: 0.479–0.836), but not in Tibeto-Burmans. Nonetheless, these alleles were not in Hardy-Weinberg Equilibrium in Tibeto-Burmans (<italic>P</italic> &lt; 0.001). In contrast, the <italic>TLR9</italic> 1486T/C genotype was favourable where it was negatively associated with complicated malaria (Fishers exact <italic>P</italic> = 0.014). Sequencing data revealed that the two populations differed in nucleotide diversity of the <italic>TLR9</italic> promoter region. Enhanced expression of <italic>TLR4</italic> (<italic>P</italic> = 0.05), but not of <italic>TLR9</italic>, was associated with complicated malaria. Austro-Asiatics appeared to have accumulated favourable genotypes of <italic>TLR9</italic>, perhaps because of their longer exposure to malaria.</p>
</abstract>
<kwd-group>
<kwd>Austro-Asiatic</kwd>
<kwd>malaria</kwd>
<kwd>Tibeto-Burman</kwd>
<kwd>Toll-like receptors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1753425912455675" sec-type="intro"><title>Introduction</title>
<p>Innate immunity is gaining importance in the understanding of immune responses to infectious organisms. Cells of the immune system armed with germ-line encoded receptors (pathogen recognition receptors) of limited repertoires respond to the molecular motifs on exogenous antigens by secreting cytokines and chemokines that significantly influence adaptive immunity and disease outcome.<sup><xref ref-type="bibr" rid="bibr1-1753425912455675">1</xref></sup></p>
<p>TLRs are an important component of the innate immune system. Their role in bacterial and viral infections is well documented and they are becoming important in immune responses to protozoan infections.<sup><xref ref-type="bibr" rid="bibr2-1753425912455675">2</xref><xref ref-type="bibr" rid="bibr3-1753425912455675"/>–<xref ref-type="bibr" rid="bibr4-1753425912455675">4</xref></sup> Activation of TLRs leads not only to the robust production of pro-inflammatory mediators, but also to the production of unique effectors, which provide pathogen-tailored immune responses. In malaria, <italic>Plasmodium falciparum</italic> glycosylphosphatidylinositol (GPI) has been shown to induce the expression of proinflammatory cytokines and immune mediators <italic>in vitro.</italic><sup><xref ref-type="bibr" rid="bibr5-1753425912455675">5</xref></sup> Furthermore, GPI was reported to induce signalling via both <italic>TLR2</italic> and <italic>TLR4</italic>, whereas haemozoin (HZ), in combination with plasmodial DNA, activated dendritic cells by engaging <italic>TLR9</italic>.<sup><xref ref-type="bibr" rid="bibr6-1753425912455675">6</xref></sup> Changes in TLR responses also modulated the production of inflammatory cytokines and thus prevented the development of severe pathology, emphasising the role of these responses in malarial pathogenesis.<sup><xref ref-type="bibr" rid="bibr7-1753425912455675">7</xref></sup> Increased expression of TLR genes was also seen in <italic>P. falciparum</italic> infected subjects and it was associated with enhanced IFN-γ, TNF-α and IL-10 production.<sup><xref ref-type="bibr" rid="bibr8-1753425912455675">8</xref></sup></p>
<p>Genetic variations of TLRs can change the ability of the organism to respond to different stimuli, hence the interest in the possible associations of TLR polymorphisms with altered susceptibility to infections and inflammatory diseases is growing.<sup><xref ref-type="bibr" rid="bibr2-1753425912455675">2</xref></sup> Studies have linked <italic>TLR2</italic> (Arg753Gln) with rheumatic fever in children and <italic>TLR4</italic> polymorphisms with increased susceptibility to bacterial infections.<sup><xref ref-type="bibr" rid="bibr9-1753425912455675">9</xref><xref ref-type="bibr" rid="bibr10-1753425912455675"/>–<xref ref-type="bibr" rid="bibr11-1753425912455675">11</xref></sup> <italic>TLR9</italic> promoter polymorphisms (T-1237C and T-1486C) have been assumed to influence transcription regulation and they have been associated with asthma, Crohns disease, atopic eczema and lymphoma.<sup><xref ref-type="bibr" rid="bibr12-1753425912455675">12</xref><xref ref-type="bibr" rid="bibr13-1753425912455675"/>–<xref ref-type="bibr" rid="bibr14-1753425912455675">14</xref></sup> Many studies have also implicated polymorphisms of <italic>TLR2</italic>, <italic>4</italic> and <italic>9</italic> in the disease manifestation of malaria. Single nucleotide polymorphisms (SNPs) of <italic>TLR4</italic> (Asp299Gly) and <italic>TLR9</italic> (T-1486C), but not <italic>TLR9</italic> (T-1237C), were associated with low birth rate, maternal anaemia and with high parasitaemia, suggesting that these SNPs play a role in the manifestation of malaria during pregnancy.<sup><xref ref-type="bibr" rid="bibr15-1753425912455675">15</xref>,<xref ref-type="bibr" rid="bibr16-1753425912455675">16</xref></sup> SNPs of <italic>TLR4</italic> Asp299Gly and Thr399Ile were seen to increase the risk of severe malaria in Ghanian children.<sup><xref ref-type="bibr" rid="bibr15-1753425912455675">15</xref>,<xref ref-type="bibr" rid="bibr17-1753425912455675">17</xref></sup></p>
<p>A number of SNPs associated with inflammatory and immunologic diseases also show large frequency differences among ethnically-distinct populations.<sup><xref ref-type="bibr" rid="bibr2-1753425912455675">2</xref>,<xref ref-type="bibr" rid="bibr18-1753425912455675">18</xref></sup> A study in India, showed that high frequency of <italic>FcγR2A exon4 AA</italic> genotype protected the Tharus, a population living in the foothills of the Himalayas, from <italic>falciparum</italic> malaria.<sup><xref ref-type="bibr" rid="bibr19-1753425912455675">19</xref></sup></p>
<p>Distribution of TLR polymorphisms have been shown to differ among ethnically different populations in Asia, Africa and Europe, and malaria was suggested to be the driving force.<sup><xref ref-type="bibr" rid="bibr20-1753425912455675">20</xref></sup> In this context, we have examined the association of SNPs in <italic>TLR4</italic> and <italic>9</italic>, and the expression of these genes in relation to malaria and ethnicity in Assam State of northeast India, in which malaria is endemic.<sup><xref ref-type="bibr" rid="bibr21-1753425912455675">21</xref></sup> We report the differential association of polymorphisms and expression of <italic>TLR9</italic> with malaria in two ethnic groups. Increased expression of <italic>TLR4</italic> gene was seen in complicated malaria. The Austro-Asiatics (plains) had the favourable genotype, conferring protection from complicated malaria.</p>
</sec>
<sec id="sec2-1753425912455675" sec-type="materials|methods"><title>Materials and methods</title>
<sec id="sec3-1753425912455675"><title>Study sites</title>
<p>The study was conducted at two study sites: Guabari, a village of Baksa district which lies at the foothills of Bhutan; and at Kondoli in Karbi Anglong foothills of Nagaon district of Assam. The two study sites may be classified as mesoendemic for malaria. The characteristics of the two study sites have been described previously.<sup><xref ref-type="bibr" rid="bibr22-1753425912455675">22</xref></sup></p>
</sec>
<sec id="sec4-1753425912455675"><title>Study participants</title>
<p>Patients were enrolled into the study after obtaining written informed consent. Active, as well as passive, case detection was followed which was carried out by local health workers in Guabari, while at Kondoli it was done by hospital staff. Based on linguistic group affinities, the study population was stratified into two groups, namely the speakers of Tibeto-Burman (TB) that included the Bodo-Kachari and Nepalis, the Austro-Asiatic (AA) that comprised the tea tribes who are Mundari speakers.<sup><xref ref-type="bibr" rid="bibr19-1753425912455675">19</xref></sup> Sampling was done such that the samples were drawn independently and randomly from each group, particularly at Guabari, which has an ethnically-mixed population. Though the people belonging to AA and TB groups are found in Assam at present, but their origin is very different. The AA group is believed to include the earliest inhabitants of Indian plains whereas the TBs are believed to have migrated from South China and Tibet approximately 5000–10,000 years ago.<sup><xref ref-type="bibr" rid="bibr23-1753425912455675">23</xref><xref ref-type="bibr" rid="bibr24-1753425912455675"/>–<xref ref-type="bibr" rid="bibr25-1753425912455675">25</xref></sup> Moreover, based on mitochondrial DNA and NRY (non-recombing region of the Y chromosome) haplotypes, the AA was found to be genetically distinct from TB.<sup><xref ref-type="bibr" rid="bibr25-1753425912455675">25</xref></sup> Khasis are a group of people residing in the state of Meghalaya and they are AA because their language belongs to the Khasi-Khmic subfamily of the AAs.<sup><xref ref-type="bibr" rid="bibr26-1753425912455675">26,27</xref></sup> In the present study, the AA group from Assam was denoted as AA (plains) and the Khasis as AA (hills). Khasi participants (<italic>n</italic> = 30) were from hilly regions (&gt;4900 ft above sea-level) where exposure to malaria is unlikely and so served as controls for AA (plains) in SNP-malaria association studies.</p>
</sec>
<sec id="sec5-1753425912455675"><title>Sample collection</title>
<p>Blood samples were obtained from individuals, irrespective of their <italic>P. falciparum</italic>-positive (Pf+) status at the time of collection. Inclusion criteria were individuals with Pf+ or with history of falciparum malaria. Exclusion criteria were children with age less than 1 year, pregnant women and individuals suffering from any other diseases. <italic>Plasmodium falciparum</italic> positivity was checked using Rapid Diagnostic Kits (FalciVax; Orchid Biomedical Laboratories, Goa, India), and confirmed by microscopy of thin and thick blood smears. Individuals were categorized according to their disease symptoms and frequency of malaria incidence, which were recorded simultaneously. Complicated malaria was defined following World Health Organization (WHO) guidelines.<sup><xref ref-type="bibr" rid="bibr28-1753425912455675">28</xref></sup> Uncomplicated malaria included fever, headache, body ache, and other mild symptoms or asymptomatic cases with parasitaemia of ≤5000/µl of blood. On the basis of number of clinical episodes of malaria, the participants were classified as infrequent (≤2 episodes) or frequent malaria (&gt;2 episodes) groups as detailed in our earlier work.<sup><xref ref-type="bibr" rid="bibr29-1753425912455675">29</xref></sup> The study was approved by the Tezpur University Ethical Committee (Resolution number 3 dated 13 June 2006).</p>
</sec>
<sec id="sec6-1753425912455675"><title>SNP typing of TLR4 and 9</title>
<p>Two hundred microlitres of blood were collected in EDTA-tubes and genomic DNA extraction was carried out using Qiagen blood extraction kit (Qiagen, Hilden, Germany). The <italic>TLR4</italic> and <italic>9</italic> genes were amplified by PCR and then digested using restriction enzymes, as described.<sup><xref ref-type="bibr" rid="bibr10-1753425912455675">10</xref>,<xref ref-type="bibr" rid="bibr30-1753425912455675">30</xref><xref ref-type="bibr" rid="bibr31-1753425912455675"/>–<xref ref-type="bibr" rid="bibr32-1753425912455675">32</xref></sup> The fragments were then analysed on 3% agarose gels pre-stained with ethidium bromide.</p>
</sec>
<sec id="sec7-1753425912455675"><title>Sequence analysis</title>
<p><italic>TLR9</italic> promoter regions were sequenced (Sequencer; Applied Biosystems, Foster City, CA) and aligned with the sequence available in the GenBank (Accession number: NT_022517.18) using CLUSTAL X and the matrix selected for the purpose is Clustal W 1.6. The alignment file created was used for further analysis using DNASp V 5.0. <italic>TLR9</italic> promoter sequences have been submitted to GenBank with the following accession numbers: HM231310, HM231311, HM231312 and HM231313.</p>
</sec>
<sec id="sec8-1753425912455675"><title>TLR gene expression study</title>
<p>The cohort used for the <italic>TLR4</italic> and <italic>9</italic> genotyping study was also used for expression study. Forty-six samples were drawn randomly from each of the three diseased groups (comprising of patients having complicated malaria, uncomplicated malaria and non-malarial fever) and from the healthy control group. Total RNA was then extracted from these blood samples and stored in RNA later, as per the manufacturer’s instructions (Ribopure; Ambion, Invitrogen BioServices, India). Reverse transcription (RT) reactions were set up by using cDNA Archive kit (Applied Biosystems, Foster City, CA). Real time PCR was performed in 7300 Real time PCR system (Applied Biosystems, Foster City, CA). TLR genes expression was calculated in relation to the expression of RnaseP, which was used as an endogenous control.<sup><xref ref-type="bibr" rid="bibr33-1753425912455675">33</xref></sup></p>
</sec>
<sec id="sec9-1753425912455675"><title>Data analysis</title>
<p>The data was analysed using Excel Stat Software, 2010 version. Variation in the frequency of the <italic>TLR4</italic> and <italic>9</italic> genes with respect to disease status, frequency of disease and ethnicity was analysed by Fisher’s exact test. The allele frequencies were calculated (estimation of <italic>P</italic> values by Pearson test) to test if they were in agreement with Hardy–Weinberg equilibrium (HWE). For TLR gene expression data analysis we used the comparative CT method (ΔΔCT method). Expression of TLR genes was analysed by <italic>t</italic>-test used for comparing the means in the different groups. Expression levels of TLR genes were compared between the younger age group (≤10 years) and older age group (&gt;10 years) who had malaria at that point in time.</p>
</sec>
</sec>
<sec id="sec10-1753425912455675" sec-type="results"><title>Results</title>
<sec id="sec11-1753425912455675"><title>Overall frequency of SNPs of TLR genes</title>
<p>A total of 191 samples were studied, where we found median age of the participants was 26.174 (range: 2–58 years). The younger age group (2–10 years) was seen to have a higher mean parasitaemia of 2526.09 ± 1764.92 trophozoites/μl of blood than the older age group (11–58 years) which was 1816.833 ± 700.9 trophozoites/μl of blood. These samples were examined for the frequency of SNPs in <italic>TLR4</italic> (Asp299Gly), <italic>TLR9</italic> (T-1237C) and (T-1486C) (<xref ref-type="table" rid="table1-1753425912455675">Table 1</xref>). The mutant alleles of <italic>TLR9</italic> were seen predominantly in heterozygosity in the three ethnic groups. In case of <italic>TLR4</italic>, the wild genotype (A/A) was seen to dominate. The two alleles of <italic>TLR4</italic> were not in HWE, neither in the overall population nor in each of the two ethnic groups (<italic>P</italic> &lt; 0.001) (<xref ref-type="table" rid="table2-1753425912455675">Table 2</xref>). The frequency of the homozygous mutant genotype of the studied TLR genes was low except for <italic>TLR9</italic> (T-1486C) where it was seen to be present at higher frequency in the TB (Fishers exact <italic>P</italic> = 0.014; <xref ref-type="table" rid="table1-1753425912455675">Table 1</xref>). The genotype frequencies of <italic>TLR4</italic> and <italic>9</italic> were compared between AA (hills) and AA (plains), and were comparable (<xref ref-type="table" rid="table3-1753425912455675">Table 3</xref>), suggesting that malaria may not be a factor for the variation.
<table-wrap id="table1-1753425912455675" position="float"><label>Table 1.</label><caption><p>Comparison of the genotype frequencies of the <italic>TLR4</italic> and <italic>9</italic> loci in the study population. Analysis was performed to check the interactions in the three genotypes of each TLR gene by Fisher’s exact test.</p></caption>
<graphic alternate-form-of="table1-1753425912455675" xlink:href="10.1177_1753425912455675-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th colspan="5"><italic>TLR4</italic> Asp299Gly<hr/></th>
</tr>
<tr><th>Genotype</th>
<th><italic>n</italic></th>
<th>AA</th>
<th>GG</th>
<th>AG</th>
<th><italic>P</italic> value</th>
</tr></thead>
<tbody align="left">
<tr>
<td>AA(plains)</td>
<td>79</td>
<td>65</td>
<td>4</td>
<td>10</td>
<td rowspan="2">0.89<hr/></td>
</tr>
<tr>
<td>TB<hr/></td>
<td>75<hr/></td>
<td>64<hr/></td>
<td>3<hr/></td>
<td>8<hr/></td>
</tr>
<tr>
<td/>
<td colspan="5"><italic>TLR9</italic> (T-1237C)<hr/></td>
</tr>
<tr>
<td>Genotype<hr/></td>
<td><italic>n</italic><hr/></td>
<td>TT<hr/></td>
<td>CC<hr/></td>
<td>TC<hr/></td>
<td><italic>P</italic> value<hr/></td>
</tr>
<tr>
<td>AA(plains)</td>
<td>81</td>
<td>25</td>
<td>0</td>
<td>56</td>
<td rowspan="2">0.43<hr/></td>
</tr>
<tr>
<td>TB<hr/></td>
<td>74<hr/></td>
<td>21<hr/></td>
<td>2<hr/></td>
<td>51<hr/></td>
</tr>
<tr>
<td/>
<td colspan="5"><italic>TLR9</italic> (T-1486C)<hr/></td>
</tr>
<tr>
<td>Genotype<hr/></td>
<td><italic>n</italic><hr/></td>
<td>TT<hr/></td>
<td>CC<hr/></td>
<td>TC<hr/></td>
<td><italic>P</italic> value<hr/></td>
</tr>
<tr>
<td>AA (plains)</td>
<td>75</td>
<td>32</td>
<td>7</td>
<td>36</td>
<td rowspan="2"><sup><xref ref-type="table-fn" rid="table-fn1-1753425912455675">a</xref></sup>0.014</td>
</tr>
<tr>
<td>TB</td>
<td>80</td>
<td>18</td>
<td>16</td>
<td>46</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1753425912455675"><label>a</label><p><italic>P</italic> value is significant (<italic>P</italic> &lt; 0.05). number of samples.</p></fn>
<fn id="table-fn2-1753425912455675"><p>AA, Austro-Asiatic; TB, Tibeto-Burman.</p></fn></table-wrap-foot>
</table-wrap>
<table-wrap id="table2-1753425912455675" position="float"><label>Table 2.</label><caption><p>Comparison of the allele frequencies of the SNPs of <italic>TLR4</italic> and <italic>9</italic> loci in the study population.</p></caption>
<graphic alternate-form-of="table2-1753425912455675" xlink:href="10.1177_1753425912455675-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">SNP</th>
<th colspan="2">Overall population <italic>n</italic> = 191<hr/></th>
<th colspan="2">AA <italic>n</italic> = 111<hr/></th>
<th colspan="2">TB <italic>n</italic> = 80<hr/></th>
</tr>
<tr><th>W allele</th>
<th>M allele</th>
<th>W allele</th>
<th>M allele</th>
<th>W allele</th>
<th>M allele</th>
</tr></thead>
<tbody align="left">
<tr>
<td><italic>TLR4</italic> Asp299Gly</td>
<td><sup>a</sup>0.895</td>
<td><sup>a</sup>0.105</td>
<td><sup>b</sup>0.89</td>
<td><sup>b</sup>0.11</td>
<td><sup>d</sup>0.9</td>
<td><sup>d</sup>0.1</td>
</tr>
<tr>
<td><italic>TLR9</italic> (T-1237C)</td>
<td><sup>f</sup>0.64</td>
<td><sup>f</sup>0.36</td>
<td><sup>e</sup>0.65</td>
<td><sup>e</sup>0.35</td>
<td><sup>c</sup>0.628</td>
<td><sup>c</sup>0.372</td>
</tr>
<tr>
<td><italic>TLR9</italic> (T-1486C)</td>
<td>0.587</td>
<td>0.413</td>
<td>0.66</td>
<td>0.34</td>
<td>0.512</td>
<td>0.488</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1753425912455675"><label>a–f</label><p>Allele frequencies were not in Hardy-Weinberg Equilibrium (Pearsons <italic>P</italic> &lt; 0.05). Allele frequencies of <italic>TLR4</italic> suggest that there is a low prevalence of the mutation in the study population.</p></fn>
<fn id="table-fn4-1753425912455675"><p>AA, Austro-Asiatic; TB, Tibeto-Burman; W, wild; M, mutant.</p></fn></table-wrap-foot>
</table-wrap>
<table-wrap id="table3-1753425912455675" position="float"><label>Table 3.</label><caption><p>Comparison of the genotype frequencies of the <italic>TLR4</italic> and <italic>9</italic> between Austro-Asiatics (AA) (plains) and AA (hills).</p></caption>
<graphic alternate-form-of="table3-1753425912455675" xlink:href="10.1177_1753425912455675-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th colspan="5"><italic>TLR4</italic> Asp299Gly<hr/></th>
</tr>
<tr><th>Genotype</th>
<th><italic>n</italic></th>
<th>AA</th>
<th>GG</th>
<th>AG</th>
<th><italic>P</italic> value</th>
</tr></thead>
<tbody align="left">
<tr>
<td>AA (plains)</td>
<td>79</td>
<td>65</td>
<td>4</td>
<td>10</td>
<td rowspan="2">0.685<hr/></td>
</tr>
<tr>
<td>AA (hills)<hr/></td>
<td>30<hr/></td>
<td>26<hr/></td>
<td>0<hr/></td>
<td>4<hr/></td>
</tr>
<tr>
<td/>
<td colspan="5"><italic>TLR9</italic> (T-1237C)<hr/></td>
</tr>
<tr>
<td> Genotype<hr/></td>
<td><italic>n</italic><hr/></td>
<td>TT<hr/></td>
<td>CC<hr/></td>
<td>TC<hr/></td>
<td><italic>P</italic> value<hr/></td>
</tr>
<tr>
<td>AA (plains)</td>
<td>81</td>
<td>25</td>
<td>0</td>
<td>56</td>
<td rowspan="2">0.123<hr/></td>
</tr>
<tr>
<td>AA (hills)<hr/></td>
<td>30<hr/></td>
<td>5<hr/></td>
<td>0<hr/></td>
<td>25<hr/></td>
</tr>
<tr>
<td/>
<td colspan="5"><italic>TLR9</italic> (T-1486C)<hr/></td>
</tr>
<tr>
<td> Genotype<hr/></td>
<td><italic>n</italic><hr/></td>
<td>TT<hr/></td>
<td>CC<hr/></td>
<td>TC<hr/></td>
<td><italic>P</italic> value<hr/></td>
</tr>
<tr>
<td>AA (plains)</td>
<td>75</td>
<td>32</td>
<td>7</td>
<td>36</td>
<td rowspan="2">0.20</td>
</tr>
<tr>
<td>AA (hills)</td>
<td>30</td>
<td>7</td>
<td>4</td>
<td>18</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1753425912455675"><p>Analysis was performed to check the interactions in the three genotypes of each TLR gene by Fisher’s exact test between the Mundari speakers, AA (plains) and the Khasi-Khmic AA (hills) subfamilies of the AAs.</p></fn></table-wrap-foot>
</table-wrap>
</p>
</sec>
<sec id="sec12-1753425912455675"><title>Sequence analysis</title>
<p>Differences in SNP frequencies in the two ethnic groups were further analysed by sequencing the PCR products of <italic>TLR9</italic> promoter region. The sequences were compared with the sequence data present in Gen Bank (GenBank accession number: NT_022517.18). Analysis of the two subject populations with the sequence present in Gen Bank showed that the TB population had a maximum variation in the nucleotide sequence in the range of nucleotide from 162–340 over 178 base pair (bp) length (<xref ref-type="fig" rid="fig1-1753425912455675">Figure 1A</xref>). In contrast, in the AA population, variation was seen in the later part of the sequence over a region of 180 bp, lying in range of nucleotide number 420–600 (<xref ref-type="fig" rid="fig1-1753425912455675">Figure 1B</xref>).
<fig id="fig1-1753425912455675" position="float"><label>Figure 1.</label><caption><p>Comparison of nucleotide divergence. The figure compares nucleotide divergence (A) between Tibeto-Burman (TB) and GenBank (NT_022517.18) (B) between Austro-Asiatic (AA) and GenBank (NT_022517.18) and (C) between AA and TB. Pi, nucleotide diversity, the average number of nucleotide differences per site between two sequences; Dxy, average number of nucleotide substitution per site between populations; Da, number of net nucleotide substitutions per site between populations. Alignment of the sequences was done using CLUSTAL X and further analysis using DNASp V 5.0.</p></caption><graphic xlink:href="10.1177_1753425912455675-fig1.tif"/>
</fig></p>
<p>Analysis between the two populations showed a distinct pattern in the number of nucleotide variation, as shown in <xref ref-type="fig" rid="fig1-1753425912455675">Figure 1C</xref>, where the TB population showed maximum variation in the first 200 bp region while the AA population was seen to show maximum variations in the 400–600 bp region.</p>
</sec>
<sec id="sec13-1753425912455675"><title>Association of SNPs of TLR4 and 9 genes with malaria</title>
<p>We analysed the frequency of SNPs in relation to disease severity: complicated malaria and uncomplicated malaria and with respect to frequency of episodes.</p>
</sec>
<sec id="sec14-1753425912455675"><title>Complicated and uncomplicated malaria</title>
<p>Frequency of <italic>TLR4</italic> (Asp299Gly) was comparable, irrespective of disease status and ethnicity (<xref ref-type="table" rid="table4-1753425912455675">Table 4</xref>). Overall frequency of <italic>TLR9</italic> 1237T/T genotype was higher in the uncomplicated group (Fisher’s exact <italic>P</italic> = 0.009), whereas T/C genotype was seen at higher frequency in the complicated group. Stratifying data on the basis of ethnicity, T/T genotype was seen at higher frequency in AA (plains) in the uncomplicated group, suggesting an association of <italic>TLR9</italic> (T-1237C) mutation with complicated malaria (relative risk = 0.595 95% CI: 0.479–0.836; Fisher’s exact <italic>P</italic> = 0.001; <xref ref-type="table" rid="table4-1753425912455675">Table 4</xref>). In TB too, the frequency of T/T genotype was higher in the uncomplicated malaria group but did not reach statistical significance (<italic>P</italic> &gt; 0.05). Interestingly, this mutation was not in HWE in either AA (plains) or TB (<italic>P</italic> &lt; 0.001), suggesting this could be under selection in these populations (<xref ref-type="table" rid="table2-1753425912455675">Table 2</xref>). Intriguingly, for <italic>TLR9</italic>, the 1486T/C genotype was found to be protective in TB where it was negatively associated with complicated malaria (Fisher’s exact <italic>P</italic> = 0.01; <xref ref-type="table" rid="table4-1753425912455675">Table 4</xref>).
<table-wrap id="table4-1753425912455675" position="float"><label>Table 4.</label><caption><p>Comparison of the genotype frequencies of the SNPs of <italic>TLR4</italic> and <italic>9</italic> in the two ethnicities in complicated and uncomplicated malaria groups. Analysis was performed to check the interactions in the three genotypes of each TLR gene.</p></caption>
<graphic alternate-form-of="table4-1753425912455675" xlink:href="10.1177_1753425912455675-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th/>
<th colspan="4">AA<hr/></th>
<th/>
<th colspan="4">TB<hr/></th>
</tr>
<tr><th>SNP</th>
<th>Genotype</th>
<th><italic>n</italic></th>
<th>Com M</th>
<th>Un Com</th>
<th><italic>P</italic> value</th>
<th><italic>n</italic></th>
<th>Com M</th>
<th>Un Com</th>
<th><italic>P</italic> value</th>
</tr></thead>
<tbody align="left">
<tr>
<td><italic>TLR4</italic></td>
<td>AA</td>
<td/>
<td>24</td>
<td>40</td>
<td/>
<td/>
<td>26</td>
<td>38</td>
<td/>
</tr>
<tr>
<td>Asp299Gly</td>
<td>GG</td>
<td>78</td>
<td>2</td>
<td>2</td>
<td>0.57</td>
<td>75</td>
<td>1</td>
<td>2</td>
<td>0.87</td>
</tr>
<tr>
<td/>
<td>AG</td>
<td/>
<td>5</td>
<td>5</td>
<td/>
<td/>
<td>4</td>
<td>4</td>
<td/>
</tr>
<tr>
<td><italic>TLR9</italic></td>
<td>TT</td>
<td/>
<td>4</td>
<td>21</td>
<td/>
<td/>
<td>7</td>
<td>14</td>
<td/>
</tr>
<tr>
<td>(T-1237C)</td>
<td>CC</td>
<td>81</td>
<td>0</td>
<td>0</td>
<td><sup>a</sup>0.001</td>
<td>74</td>
<td>1</td>
<td>1</td>
<td>0.80</td>
</tr>
<tr>
<td/>
<td>TC</td>
<td/>
<td>30</td>
<td>26</td>
<td/>
<td/>
<td>21</td>
<td>30</td>
<td/>
</tr>
<tr>
<td><italic>TLR9</italic></td>
<td>TT</td>
<td/>
<td>14</td>
<td>18</td>
<td/>
<td/>
<td>9</td>
<td>9</td>
<td/>
</tr>
<tr>
<td>(T-1486C)</td>
<td>CC</td>
<td>75</td>
<td>1</td>
<td>6</td>
<td>0.28</td>
<td>77</td>
<td>10</td>
<td>6</td>
<td><sup>b</sup>0.01</td>
</tr>
<tr>
<td/>
<td>TC</td>
<td/>
<td>13</td>
<td>23</td>
<td/>
<td/>
<td>11</td>
<td>32</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1753425912455675"><label>a,b</label><p><italic>P</italic> values are significant (<italic>P</italic> &lt; 0.05).</p></fn>
<fn id="table-fn7-1753425912455675"><p>AA, Austro-Asiatic; TB, Tibeto-Burman; Com M, complicated malaria; Un Com, uncomplicated malaria.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec15-1753425912455675"><title>Frequency of the disease (number of episodes)</title>
<p>The frequencies of SNPs in <italic>TLR4</italic> and <italic>9</italic> genes were unrelated to frequency of the disease. When the data was stratified according to ethnicity, we found that malaria occurred less frequently in absence of (T-1237C) mutation of <italic>TLR9</italic> in AA (plains) (<italic>P</italic> = 0.035; <xref ref-type="table" rid="table5-1753425912455675">Table 5</xref>), indicating the mutation was not favourable to malaria outcome.
<table-wrap id="table5-1753425912455675" position="float"><label>Table 5.</label><caption><p>Comparison of the genotype frequencies of the SNPs of <italic>TLR4</italic> and <italic>TLR9</italic> in the two ethnicities in frequent and infrequent malaria episodes.</p></caption>
<graphic alternate-form-of="table5-1753425912455675" xlink:href="10.1177_1753425912455675-table5.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th/>
<th colspan="4">AA<hr/></th>
<th colspan="4">TB<hr/></th>
</tr>
<tr><th>SNP</th>
<th>Genotype</th>
<th><italic>n</italic></th>
<th>F</th>
<th>IF</th>
<th><italic>P</italic> values</th>
<th><italic>n</italic></th>
<th>F</th>
<th>IF</th>
<th><italic>P</italic> values</th>
</tr></thead>
<tbody align="left">
<tr>
<td><italic>TLR4</italic></td>
<td>AA</td>
<td/>
<td>30</td>
<td>34</td>
<td/>
<td/>
<td>28</td>
<td>36</td>
<td/>
</tr>
<tr>
<td>Asp299Gly</td>
<td>GG</td>
<td>78</td>
<td>2</td>
<td>2</td>
<td>0.3</td>
<td>75</td>
<td>1</td>
<td>2</td>
<td>0.5</td>
</tr>
<tr>
<td/>
<td>AG</td>
<td/>
<td>7</td>
<td>3</td>
<td/>
<td/>
<td>5</td>
<td>3</td>
<td/>
</tr>
<tr>
<td><italic>TLR9</italic></td>
<td>TT</td>
<td/>
<td>11</td>
<td>14</td>
<td/>
<td/>
<td>10</td>
<td>11</td>
<td/>
</tr>
<tr>
<td>(T-1237C)</td>
<td>CC</td>
<td>81</td>
<td>0</td>
<td>0</td>
<td><sup><xref ref-type="table-fn" rid="table-fn4-1753425912455675">a</xref></sup>0.035</td>
<td>74</td>
<td>1</td>
<td>1</td>
<td>0.3</td>
</tr>
<tr>
<td/>
<td>TC</td>
<td/>
<td>40</td>
<td>16</td>
<td/>
<td/>
<td>16</td>
<td>35</td>
<td/>
</tr>
<tr>
<td><italic>TLR9</italic></td>
<td>TT</td>
<td/>
<td>19</td>
<td>13</td>
<td/>
<td/>
<td>8</td>
<td>10</td>
<td/>
</tr>
<tr>
<td>(T-1486C)</td>
<td>CC</td>
<td>75</td>
<td>3</td>
<td>4</td>
<td>0.6</td>
<td>77</td>
<td>8</td>
<td>8</td>
<td>0.9</td>
</tr>
<tr>
<td/>
<td>TC</td>
<td/>
<td>18</td>
<td>18</td>
<td/>
<td/>
<td>20</td>
<td>23</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-1753425912455675"><p>Comparison of the frequency of the given SNPs between frequent and infrequent malaria episodes in the two ethnic groups. Analysis was done using χ<sup>2</sup> test to check whether the frequencies of SNPs in <italic>TLR4</italic> and <italic>TLR9</italic> genes were related to frequency of the disease. Significant difference was seen only for <italic>TLR9</italic> (T-1237C)</p></fn>
<fn id="table-fn9-1753425912455675"><label>a</label><p>Between frequent and infrequent malaria episodes in AA and TB.</p></fn>
<fn id="table-fn10-1753425912455675"><p>F, frequent; IF, infrequent; AA, Austro-Asiatic; TB, Tibeto-Burman.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec16-1753425912455675"><title>SNP grouping of TLR9</title>
<p>Based on the combination of the presence or absence of the wild and mutant alleles for the two SNPs of <italic>TLR9</italic> (T-1237C and T-1486C) a total of eight groups could be identified (<xref ref-type="table" rid="table6-1753425912455675">Table 6</xref>). Group 1, with co-occurrence of the two mutations in heterozygosity, was seen to be the dominant group and occurred in 67 individuals. Interestingly, 77.77% of the individuals of this group belonged to the uncomplicated group (Kruskal-Wallis test <italic>P</italic> = 0.05), suggesting its association with protection from having complicated malaria. Group 4, which contained the T/T genotype of both mutations, was more frequent than group 7 containing C/C genotype for both the polymorphisms. In group 4, 9 individuals were of AA (plains) and 76.9% of them suffered from complicated malaria (<xref ref-type="table" rid="table6-1753425912455675">Table 6</xref>).
<table-wrap id="table6-1753425912455675" position="float"><label>Table 6.</label><caption><p>SNP-grouping of <italic>TLR9</italic> (T-1237C and T-1486C) in the study population. Black and white fields denote the presence and absence of wild or mutant alleles respectively.</p></caption>
<graphic alternate-form-of="table6-1753425912455675" xlink:href="10.1177_1753425912455675-table6.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Group</th>
<th>T1237C<hr/></th>
<th>T1237C<hr/></th>
<th>T1486C<hr/></th>
<th>T1486C<hr/></th>
<th rowspan="2">Genotype</th>
<th rowspan="2">Total (Pf+ and control)</th>
<th colspan="2">In relation to malaria severity<hr/></th>
</tr>
<tr><th>W</th>
<th>M</th>
<th>W</th>
<th>M</th>
<th>CM</th>
<th>UCM</th>
</tr></thead>
<tbody align="left">
<tr>
<td>1</td>
<td/>
<td/>
<td/>
<td/>
<td>TCTC</td>
<td>67</td>
<td>10</td>
<td>36</td>
</tr>
<tr>
<td>2</td>
<td/>
<td/>
<td/>
<td/>
<td>TCTT</td>
<td>39</td>
<td>14</td>
<td>14</td>
</tr>
<tr>
<td>3</td>
<td/>
<td/>
<td/>
<td/>
<td>TCCC</td>
<td>24</td>
<td>8</td>
<td>9</td>
</tr>
<tr>
<td>4</td>
<td/>
<td/>
<td/>
<td/>
<td>TTTT</td>
<td>17</td>
<td>1</td>
<td>13</td>
</tr>
<tr>
<td>5</td>
<td/>
<td/>
<td/>
<td/>
<td>TTCC</td>
<td>4</td>
<td>1</td>
<td>2</td>
</tr>
<tr>
<td>6</td>
<td/>
<td/>
<td/>
<td/>
<td>TTTC</td>
<td>36</td>
<td>2</td>
<td>24</td>
</tr>
<tr>
<td>7</td>
<td/>
<td/>
<td/>
<td/>
<td>CCCC</td>
<td>1</td>
<td>1</td>
<td>–</td>
</tr>
<tr>
<td>8</td>
<td/>
<td/>
<td/>
<td/>
<td>CCTC</td>
<td>1</td>
<td>–</td>
<td>1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn11-1753425912455675"><p>The participants (<italic>n</italic> = 189) positive for both the <italic>TLR9</italic> (T-1237C and T-1486C) mutations were SNP-grouped. Groups 4, 5, 7 and 8 were absent in the AA (hills). Negligible prevalence of C/C genotype for both the mutations may be noted. The proportions of complicated malaria were higher if <italic>TLR9</italic> (T-1237C) mutation was present but if it was present along with the (T-1486C) a larger proportion of uncomplicated malaria was observed.</p></fn>
<fn id="table-fn12-1753425912455675"><p>CM, complicated malaria; UCM, uncomplicated malaria; Pf+, <italic>P falciparum</italic> positive.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec17-1753425912455675"><title>TLR4 and 9 genes expression</title>
<p>Forty-six samples were analysed for the mRNA levels of <italic>TLR4</italic> and <italic>9</italic> genes and data analysed in relation to disease status. <italic>TLR4</italic> and <italic>9</italic> mRNA levels showed no difference between malaria and no malaria groups (<italic>P</italic> &gt; 0.05). When the data were analysed in the context of complicated and uncomplicated malaria (<xref ref-type="fig" rid="fig2-1753425912455675">Figure 2A</xref>), <italic>TLR4</italic> gene expression was higher in the complicated group (<italic>P</italic> = 0.05), whereas in the uncomplicated group it was lower in comparison with the no malaria group.
<fig id="fig2-1753425912455675" position="float"><label>Figure 2.</label><caption><p>Comparison of expression of <italic>TLR4</italic> and <italic>TLR9</italic> genes with disease severity and age. Mean expression of <italic>TLR4</italic> and <italic>TLR9</italic> genes was compared between complicated and uncomplicated malaria (A) and between diseased young and diseased old (B). <italic>TLR4</italic> expression was higher (<italic>P</italic> = 0.05) in complicated group (CM) in comparison with uncomplicated (UC) and no malaria (NM) groups. <italic>TLR9</italic> expression was higher (<italic>P</italic> = 0.002) in younger age group with malaria (DY) than in the older malaria group (DO).</p></caption><graphic xlink:href="10.1177_1753425912455675-fig2.tif"/>
</fig></p>
<p>As age is an important factor in immunity to malaria, the data was analysed in the context of age. <italic>TLR9</italic> expression was higher in the younger age group with clinical malaria (<italic>P</italic> = 0.002; <xref ref-type="fig" rid="fig2-1753425912455675">Figure 2B</xref>). Expression of <italic>TLR4</italic> gene was comparable between younger and older age groups with malaria (<xref ref-type="fig" rid="fig2-1753425912455675">Figure 2B</xref>).</p>
</sec>
</sec>
<sec id="sec18-1753425912455675" sec-type="discussion"><title>Discussion</title>
<p>Vertebrate TLRs play a crucial role in immune protection and have undergone selection in response to immune challenge, as noted in studies that have associated TLRs and their SNPs with diseases.<sup><xref ref-type="bibr" rid="bibr3-1753425912455675">3</xref></sup> Selection favouring homozygosity or heterozygosity is one of the mechanisms that maintain polymorphism and genetic variability. Our data indicated <italic>TLR9</italic> 1486T/C heterozygosity to be protective, while it was negatively-associated with complicated malaria, whereas <italic>TLR9</italic> (T-1237C) was seen to predispose to complicated malaria in heterozygosity. Similar findings have been reported earlier with respect to association of <italic>TLR9</italic> (T-1237C) mutation with severe malaria.<sup><xref ref-type="bibr" rid="bibr34-1753425912455675">34</xref></sup> However, our observations in context of (T-1486C) polymorphism are in contrast with earlier reports where it was associated with susceptibility to severe malaria in children and also with the adverse fetal outcome in women with placental malaria.<sup><xref ref-type="bibr" rid="bibr15-1753425912455675">15</xref>,<xref ref-type="bibr" rid="bibr17-1753425912455675">17</xref></sup> Although <italic>TLR9</italic> (T-1237C) mutation has been correlated with complicated malaria, in the presence of the (T-1486C) mutation which was associated with protection from complicated malaria, a larger proportion of uncomplicated malaria was seen in our study, suggesting that (T-1486C) was the determining mutation. Advantages conferred by heterozygosity are well documented, as in the case of sickle cell haemoglobinopathy, which affords protection against mortality from <italic>falciparum</italic> malaria in heterozygous individuals, balancing the severe consequences of the disease in homozygous individuals.<sup><xref ref-type="bibr" rid="bibr35-1753425912455675">35</xref></sup> Similarly, it was also found that those individuals with heterozygous class I and class II HLA alleles progressed from HIV infection to an AIDS-defining illness more slowly and had the ability to clear hepatitis B infection respectively.<sup><xref ref-type="bibr" rid="bibr36-1753425912455675">36</xref>,<xref ref-type="bibr" rid="bibr37-1753425912455675">37</xref></sup> We did not observe an association of SNPs and <italic>TLR4</italic>, either with malaria severity or frequency of clinical episodes. In contrast, Mockenhaupt et al. reported a higher frequency of <italic>TLR4</italic> polymorphisms Asp299Gly and Thr399Ile in malaria cases, which increased the risk of severe malaria.<sup><xref ref-type="bibr" rid="bibr15-1753425912455675">15</xref></sup> Although, the proportion of the A/A genotype of <italic>TLR4</italic> was seen to be higher in both the ethnicities in the present study, it was, however, not associated with either protection or susceptibility to malaria. <italic>TLR4</italic> alleles were not in HWE in the overall population, including each of the two ethnic groups. Natural selection acting on human <italic>TLR4</italic> ascribed to the presence of excess rare non-synonymous polymorphisms has been reported by Nakajima et al., who postulated that the selection was linked to pathogen pressure.<sup><xref ref-type="bibr" rid="bibr38-1753425912455675">38</xref></sup></p>
<p>Expression of <italic>TLR4</italic> genes was enhanced in patients having complicated malaria in the present study, which could possibly be an outcome of binding to GPI anchors of parasite surface proteins leading to increased levels of pro-inflammatory cytokines and also resulting in the up-regulation of cell adhesion molecules (ICAM-1 and VCAM-1), leading to cytoadherence.<sup><xref ref-type="bibr" rid="bibr5-1753425912455675">5</xref>,<xref ref-type="bibr" rid="bibr39-1753425912455675">39</xref></sup> An earlier study also reported increased expression of <italic>TLR4</italic> in adults with severe and mild malaria, but decreased <italic>TLR9</italic> expression in people with no history of malaria.<sup><xref ref-type="bibr" rid="bibr40-1753425912455675">40</xref></sup> Also, Coban et al. found that innate immune responses via <italic>TLR2</italic> and <italic>TLR9</italic>, and adaptor molecule MyD88-dependent pathways are critically involved in the pathogenesis of cerebral malaria.<sup><xref ref-type="bibr" rid="bibr41-1753425912455675">41</xref></sup> On the contrary, Lepenies et al. demonstrated that induction of cerebral malaria was independent of <italic>TLR2</italic>, <italic>TLR4</italic> and <italic>TLR9</italic> gene expression.<sup><xref ref-type="bibr" rid="bibr42-1753425912455675">42</xref></sup> <italic>TLR9</italic> gene expression was seen to be age-related, with higher expression in younger malaria patients. Interestingly, the proportion of uncomplicated malaria was higher in this group and may be seen as an outcome of increased <italic>TLR9</italic> gene expression, which induced an early pro-inflammatory response resulting in containment of the disease. In a parallel study we analysed the gene expression of a panel of cytokines (<italic>IL-2</italic>, <italic>IL-4</italic>, <italic>IL-8</italic>, <italic>IL-12α</italic>, <italic>IL-12β</italic>, <italic>IL-18</italic>, <italic>IFN-γ</italic>, <italic>TNF-α</italic> and <italic>TGF-β</italic>) and found that early pro-inflammatory cytokines were up-regulated in diseased cases in comparison with healthy controls (unpublished data). Increased <italic>TLR9</italic> expression could be induced by HZ, a malarial pigment formed after digestion of the haemoglobin by malarial parasites.<sup><xref ref-type="bibr" rid="bibr43-1753425912455675">43</xref></sup> It is well documented that the younger age group, generally, have higher parasitaemia and suffer more severe consequences of malaria.<sup><xref ref-type="bibr" rid="bibr44-1753425912455675">44</xref>,<xref ref-type="bibr" rid="bibr45-1753425912455675">45</xref></sup> Increased infection would result in an increased concentration of HZ in the reticulo-endothelial system, which has been demonstrated to activate the immune system by binding to <italic>TLR9</italic> and activating the downstream signaling pathway via MyD88, thereby resulting in increased <italic>TLR9</italic> expression as one of the outcomes.<sup><xref ref-type="bibr" rid="bibr6-1753425912455675">6</xref></sup> Parroche et al. also reported that HZ activates the immune system similar to Coban et al., although the mechanism of activation is different.<sup><xref ref-type="bibr" rid="bibr6-1753425912455675">6</xref>,<xref ref-type="bibr" rid="bibr43-1753425912455675">43</xref></sup> Notably, higher parasitaemia was seen in the younger age group of our study population. However, no difference in mRNA levels was seen between control and disease, which was surprising as we had observed association between the SNPs in promoter region of <italic>TLR9</italic> with disease. This was, however, not a unique finding, as, earlier, Fuse et al. had also found correlation of <italic>TLR9</italic> SNPs with Japanese ulcerative colitis, but no correlation between <italic>TLR9</italic> mRNA expression and disease.<sup><xref ref-type="bibr" rid="bibr46-1753425912455675">46</xref></sup> Modulation of <italic>TLR9</italic> gene expression through cis-regulatory variants offers an explanation for the lack of correlation between SNPs in the promoter region and levels of mRNA expression.<sup><xref ref-type="bibr" rid="bibr47-1753425912455675">47</xref></sup></p>
<p>Genetic variations in TLRs have been linked to susceptibility to infectious diseases and these variations could be the result of selective pressure on the TLR genes in those populations living in malaria-endemic areas. Ethnicity was seen to be an important factor in the association of frequency of SNPs of <italic>TLR9</italic> with malaria pathogenesis in the present study. The promoter region of <italic>TLR9</italic> was seen to vary between the AAs and TBs, as confirmed by sequencing. This was not surprising as AAs (plains) in our study group belonged to tea tribes of Mundari language affinity and are genetically distinct from TBs, based on mitochondrial DNA and NRY haplotypes.<sup><xref ref-type="bibr" rid="bibr23-1753425912455675">23</xref>,<xref ref-type="bibr" rid="bibr24-1753425912455675">24</xref></sup> Our data suggested that AA (plains) had the favourable genotype that protected them from complicated malaria as: (i) <italic>TLR9</italic> 1237T/T was seen to confer protection from complicated malaria and from frequent episodes of malaria; (ii) there was negligible <italic>TLR9</italic> 1486C/C genotype in AA, which was implicated in complicated malaria in TB. We propose that their favourable genotype could be a reflection of their longer exposure to malaria as compared with the TBs in our study group, as the AAs are believed to be the earliest inhabitants of the Indian plains.<sup><xref ref-type="bibr" rid="bibr23-1753425912455675">23</xref></sup> We also compared the genotype frequencies of <italic>TLR9</italic> between the two different AA groups and found that they did not differ, emphasizing the role of ethnicity. Thus, it may be postulated that the <italic>TLR9</italic> gene may have been under selective pressure exerted by malaria. Our observation that <italic>TLR9</italic> (T-1237C) alleles were not in HWE in TBs perhaps reflects an ongoing selection in this group, who are believed to have migrated from South China and Tibet approximately 5000–10,000 years ago.<sup><xref ref-type="bibr" rid="bibr24-1753425912455675">24</xref>,<xref ref-type="bibr" rid="bibr25-1753425912455675">25</xref></sup></p>
<p>In conclusion, <italic>TLR9</italic> (T-1237C) mutation was seen to be implicated in malaria pathogenesis. These two ethnic groups, namely AAs having genetic affinity with the earliest inhabitants of Indian plains and TBs whose origin leans more towards the Southeast Asians, have accumulated different SNPs in the <italic>TLR9</italic> promoter region as indicated from our sequencing results. Our study demonstrated that AA (plains) had the favourable genotype with respect to <italic>TLR9</italic> polymorphisms which protected them from malaria pathogenesis and this may be related to their longer exposure to malaria. While <italic>TLR9</italic> overexpression was favourable, that of <italic>TLR4</italic> was a risk factor for complicated malaria. These findings thus open the possibility of the application of <italic>TLR9</italic> SNPs as markers of population at risk of severe malaria.</p>
</sec>
</body>
<back>
<sec id="sec19-1753425912455675"><title>Funding</title>
<p>This work was supported by Department of Biotechnology, India (grant no. BT/HRD/01/002/2007) and Rajiv Gandhi National Fellowship, University Grants Commission, India (grant no. F.14-616(ST)/2008(SA-III)) to CES.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank all the participants for their cooperation in the study. Thanks to Dr Mamta Chawla, National Institute of Cholera and Enteric Diseases, Indian Council Medical Research, Kolkata for her help in the work carried out. Special thanks to Dr Anurodh Agrawal for his help.</p>
<sec id="sec20-1753425912455675"><title>Conflict of interest</title>
<p>The authors declare that there is no conflict of interest.</p>
</sec></ack>
<ref-list>
<title>References</title>
<ref id="bibr1-1753425912455675"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group>. <article-title>TLR signaling</article-title>. <source>Semin Immunol</source> <year>2007</year>; <volume>19</volume>: <fpage>24</fpage>–<lpage>32</lpage>.</citation></ref>
<ref id="bibr2-1753425912455675"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corr</surname><given-names>SC</given-names></name><name><surname>O’Neill</surname><given-names>LAJ</given-names></name></person-group>. <article-title>Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases</article-title>. <source>J Innate Immun</source> <year>2009</year>; <volume>1</volume>: <fpage>350</fpage>–<lpage>357</lpage>.</citation></ref>
<ref id="bibr3-1753425912455675"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garantziotis</surname><given-names>S</given-names></name><name><surname>Hollingsworth</surname><given-names>JW</given-names></name><name><surname>Zaas</surname><given-names>AK</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group>. <article-title>The effect of Toll-like receptors and Toll-like receptor genetics in human disease</article-title>. <source>Annu Rev Med</source> <year>2008</year>; <volume>59</volume>: <fpage>343</fpage>–<lpage>359</lpage>.</citation></ref>
<ref id="bibr4-1753425912455675"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gazzinelli</surname><given-names>RT</given-names></name><name><surname>Denkers</surname><given-names>EY</given-names></name></person-group>. <article-title>Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism</article-title>. <source>Nat Rev Immunol</source> <year>2006</year>; <volume>6</volume>: <fpage>895</fpage>–<lpage>906</lpage>.</citation></ref>
<ref id="bibr5-1753425912455675"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gowda</surname><given-names>DC</given-names></name></person-group>. <article-title>TLR-mediated cell signaling by malaria GPIs</article-title>. <source>Trend Parasitol</source> <year>2007</year>; <volume>23</volume>: <fpage>596</fpage>–<lpage>604</lpage>.</citation></ref>
<ref id="bibr6-1753425912455675"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coban</surname><given-names>C</given-names></name><name><surname>Ishii</surname><given-names>KJ</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Hemmi</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Uematsu</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Toll-like receptor 9 mediates innate immune activation by the malaria pigment haemozoin</article-title>. <source>JEM</source> <year>2005</year>; <volume>201</volume>: <fpage>19</fpage>–<lpage>25</lpage>.</citation></ref>
<ref id="bibr7-1753425912455675"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erdman</surname><given-names>LK</given-names></name><name><surname>Finney</surname><given-names>CAM</given-names></name><name><surname>Liles</surname><given-names>WC</given-names></name><name><surname>Kain</surname><given-names>KC</given-names></name></person-group>. <article-title>Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity</article-title>. <source>Mol Biochem Parasitol</source> <year>2008</year>; <volume>162</volume>: <fpage>105</fpage>–<lpage>111</lpage>.</citation></ref>
<ref id="bibr8-1753425912455675"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>BS</given-names></name><name><surname>Parroche</surname><given-names>P</given-names></name><name><surname>Ataíde</surname><given-names>MA</given-names></name><name><surname>Lauw</surname><given-names>F</given-names></name><name><surname>Ropert</surname><given-names>C</given-names></name><name><surname>de Oliveira</surname><given-names>RB</given-names></name><etal/></person-group>. <article-title>Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function</article-title>. <source>Proc Natl Acad Sci</source> <year>2009</year>; <volume>106</volume>: <fpage>5789</fpage>–<lpage>5794</lpage>.</citation></ref>
<ref id="bibr9-1753425912455675"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berdeli</surname><given-names>A</given-names></name><name><surname>Celik</surname><given-names>HA</given-names></name><name><surname>Ozyürek</surname><given-names>R</given-names></name><name><surname>Dogrusoz</surname><given-names>B</given-names></name><name><surname>Aydin</surname><given-names>HH</given-names></name></person-group>. <article-title>TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children</article-title>. <source>J Mol Med</source> <year>2005</year>; <volume>83</volume>: <fpage>535</fpage>–<lpage>541</lpage>.</citation></ref>
<ref id="bibr10-1753425912455675"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montes</surname><given-names>AH</given-names></name><name><surname>Asensi</surname><given-names>V</given-names></name><name><surname>Alvarez</surname><given-names>V</given-names></name><name><surname>Valle</surname><given-names>E</given-names></name><name><surname>Ocaña</surname><given-names>MG</given-names></name><name><surname>Meana</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The Toll-like receptor4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis</article-title>. <source>Clin Exp Immunol</source> <year>2006</year>; <volume>143</volume>: <fpage>404</fpage>–<lpage>413</lpage>.</citation></ref>
<ref id="bibr11-1753425912455675"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>E</given-names></name><name><surname>Mira</surname><given-names>JP</given-names></name><name><surname>Frees</surname><given-names>KL</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group>. <article-title>Relevance of mutations in the TLR4 receptor in patients with Gram negative septic shock</article-title>. <source>Arch Int Med</source> <year>2002</year>; <volume>162</volume>: <fpage>1028</fpage>–<lpage>1032</lpage>.</citation></ref>
<ref id="bibr12-1753425912455675"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torok</surname><given-names>HP</given-names></name><name><surname>Glas</surname><given-names>J</given-names></name><name><surname>Tonenchi</surname><given-names>L</given-names></name><name><surname>Bruennler</surname><given-names>G</given-names></name><name><surname>Folwaczny</surname><given-names>M</given-names></name><name><surname>Folwaczny</surname><given-names>C</given-names></name></person-group>. <article-title>Crohn's disease is associated with a toll-like receptor-9 polymorphism</article-title>. <source>Gastroenterology</source> <year>2004</year>; <volume>127</volume>: <fpage>365</fpage>–<lpage>366</lpage>.</citation></ref>
<ref id="bibr13-1753425912455675"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>CF</given-names></name><name><surname>Bussmann</surname><given-names>C</given-names></name><name><surname>Maintz</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>WM</given-names></name><name><surname>Hart</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Putative association of a TLR9 promoter polymorphism with atopic eczema</article-title>. <source>Allergy</source> <year>2007</year>; <volume>62</volume>: <fpage>766</fpage>–<lpage>772</lpage>.</citation></ref>
<ref id="bibr14-1753425912455675"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zauner</surname><given-names>L</given-names></name><name><surname>Melroe</surname><given-names>GT</given-names></name><name><surname>Sigrist</surname><given-names>JA</given-names></name><name><surname>Rechsteine</surname><given-names>MP</given-names></name><name><surname>Dorner</surname><given-names>M</given-names></name><name><surname>Arnold</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification</article-title>. <source>Oncogene</source> <year>2010</year>; <volume>29</volume>: <fpage>4588</fpage>–<lpage>4598</lpage>.</citation></ref>
<ref id="bibr15-1753425912455675"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mockenhaupt</surname><given-names>FP</given-names></name><name><surname>Hamann</surname><given-names>L</given-names></name><name><surname>von Gaertner</surname><given-names>C</given-names></name><name><surname>Bedu-Addo</surname><given-names>G</given-names></name><name><surname>von Kleinsorgen</surname><given-names>C</given-names></name><name><surname>Schumann</surname><given-names>RR</given-names></name><name><surname>Bienzle</surname><given-names>U</given-names></name></person-group>. <article-title>Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy</article-title>. <source>J Infect Dis</source> <year>2006</year>; <volume>194</volume>: <fpage>184</fpage>–<lpage>188</lpage>.</citation></ref>
<ref id="bibr16-1753425912455675"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leoratti</surname><given-names>FM</given-names></name><name><surname>Farias</surname><given-names>L</given-names></name><name><surname>Alves</surname><given-names>FP</given-names></name><name><surname>Suarez-Mutis</surname><given-names>MC</given-names></name><name><surname>Coura</surname><given-names>JR</given-names></name><name><surname>Kalil</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Variants in the Toll-like receptor signaling pathway and clinical outcomes of malaria</article-title>. <source>J Infect Dis</source> <year>2008</year>; <volume>198</volume>: <fpage>772</fpage>–<lpage> 780</lpage>.</citation></ref>
<ref id="bibr17-1753425912455675"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mockenhaupt</surname><given-names>FP</given-names></name><name><surname>Cramer</surname><given-names>JP</given-names></name><name><surname>Hamann</surname><given-names>L</given-names></name><name><surname>Stegemann</surname><given-names>MS</given-names></name><name><surname>Eckert</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>NR</given-names></name><etal/></person-group>. <article-title>Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria</article-title>. <source>Proc Natl Acad Sci USA</source> <year>2006</year>; <volume>103</volume>: <fpage>177</fpage>–<lpage>182</lpage>.</citation></ref>
<ref id="bibr18-1753425912455675"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>KC</given-names></name></person-group>. <article-title>Genetic determinants and ethnic disparities in sepsis-associated acute lung injury</article-title>. <source>Proc Am Thorac Soc</source> <year>2005</year>; <volume>2</volume>: <fpage>195</fpage>–<lpage>201</lpage>.</citation></ref>
<ref id="bibr19-1753425912455675"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Arya</surname><given-names>V</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Indian Genome Variation Consortium</surname></name><name><surname>Habib</surname><given-names>S</given-names></name></person-group>. <article-title>Genetic differentiation of populations residing in areas of high malaria endemicity in India</article-title>. <source>J Genet</source> <year>2009</year>; <volume>88</volume>: <fpage>77</fpage>–<lpage>80</lpage>.</citation></ref>
<ref id="bibr20-1753425912455675"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferwerda</surname><given-names>B</given-names></name><name><surname>McCalla</surname><given-names>M</given-names></name><name><surname>Alonsod</surname><given-names>S</given-names></name><name><surname>Giamarellos-Bourboulise</surname><given-names>EJ</given-names></name><name><surname>Mouktaroudie</surname><given-names>M</given-names></name><name><surname>Izagirred</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration ofmodern humans</article-title>. <source>PNAS</source> <year>2007</year>; <volume>104</volume>: <fpage>16645</fpage>–<lpage>16650</lpage>.</citation></ref>
<ref id="bibr21-1753425912455675"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dev</surname><given-names>V</given-names></name><name><surname>Hira</surname><given-names>CR</given-names></name><name><surname>Rajkhowa</surname><given-names>MK</given-names></name></person-group>. <article-title>Malaria attributable morbidity in Assam, north-eastern India</article-title>. <source>Ann Trop Med Parasitol</source> <year>2001</year>; <volume>95</volume>: <fpage>789</fpage>–<lpage>796</lpage>.</citation></ref>
<ref id="bibr22-1753425912455675"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baruah</surname><given-names>S</given-names></name><name><surname>Lourembam</surname><given-names>SD</given-names></name><name><surname>Sawian</surname><given-names>CE</given-names></name><name><surname>Goswami</surname><given-names>D</given-names></name><name><surname>Baruah</surname><given-names>I</given-names></name></person-group>. <article-title>Temporal and spatial variation in MSP1 clonal composition of <italic>Plasmodium falciparum</italic> in districts of Assam, Northeast India</article-title>. <source>Infect Genet Evol</source> <year>2009</year>; <volume>9</volume>: <fpage>853</fpage>–<lpage>859</lpage>.</citation></ref>
<ref id="bibr23-1753425912455675"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>BM</given-names></name><name><surname>Langstieh</surname><given-names>BT</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Nagaraja</surname><given-names>T</given-names></name><name><surname>Reddy</surname><given-names>ANS</given-names></name><name><surname>Meka Reddy</surname><given-names>AAG</given-names></name><etal/></person-group>. <article-title>Austro-asiatic tribes of northeast India provide hitherto missing genetic link between south and southeast Asia</article-title>. <source>PloS ONE</source> <year>2007</year>; <volume>2</volume>: <fpage>e1141</fpage>–<lpage>e1141</lpage>.</citation></ref>
<ref id="bibr24-1753425912455675"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Deka</surname><given-names>R</given-names></name><name><surname>Seielstad</surname><given-names>MT</given-names></name><name><surname>Kangwanpong</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Y chromosome haplotypes reveal prehistorical migrations to the Himalayas</article-title>. <source>Hum Genet</source> <year>2000</year>; <volume>107</volume>: <fpage>582</fpage>–<lpage>590</lpage>.</citation></ref>
<ref id="bibr25-1753425912455675"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>YB</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>On the origin of Tibetans and their genetic basis in adapting high-altitude environments</article-title>. <source>PLoS ONE</source> <year>2011</year>; <volume>6</volume>: <fpage>e17002</fpage>–<lpage>e17002</lpage>.</citation></ref>
<ref id="bibr26-1753425912455675"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Langsiteh</surname><given-names>BT</given-names></name><name><surname>Biswas</surname><given-names>S</given-names></name><name><surname>Babu</surname><given-names>JP</given-names></name><name><surname>Rao</surname><given-names>TN</given-names></name><name><surname>Thangaraj</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Asian and non-Asian origins of Mon-Khmer- and Mundari-speaking Austro-Asiatic populations of India</article-title>. <source>Am J Hum Biol</source> <year>2006</year>; <volume>18</volume>: <fpage>461</fpage>–<lpage>469</lpage>.</citation></ref>
<ref id="bibr27-1753425912455675"><label>27</label><citation citation-type="other"><comment>Diffloth G. The contribution of linguistic palaeontology to the homeland of Austro-Asiatic. In: Sagart L, Blench R, Sanchez-Mazas A (eds) <italic>The peopling of East Asia: putting together archaeology</italic>. London: Routledge Curzon</comment>.</citation></ref>
<ref id="bibr28-1753425912455675"><label>28</label><citation citation-type="journal"><collab>World Health Organization</collab>. <article-title>Severe falciparum malaria</article-title>. <source>Trans R Soc Trop Med Hyg</source> <year>2000</year>; <volume>94</volume><supplement>Suppl. 1</supplement><fpage>S1</fpage>–<lpage>S90</lpage>.</citation></ref>
<ref id="bibr29-1753425912455675"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lourembam</surname><given-names>S</given-names></name><name><surname>Sawian</surname><given-names>CE</given-names></name><name><surname>Baruah</surname><given-names>S</given-names></name></person-group>. <article-title>Differential association of KIR gene loci to risk of malaria in ethnic groups of Assam, Northeast India</article-title>. <source>Infect Genet Evol</source> <year>2011</year>; <volume>11</volume>: <fpage>1921</fpage>–<lpage>1928</lpage>.</citation></ref>
<ref id="bibr30-1753425912455675"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>L</given-names></name><name><surname>Hamprecht</surname><given-names>A</given-names></name><name><surname>Gomma</surname><given-names>A</given-names></name><name><surname>Schumann</surname><given-names>RR</given-names></name></person-group>. <article-title>Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2,-4 and -9 genes</article-title>. <source>JIM</source> <year>2004</year>; <volume>284</volume>: <fpage>281</fpage>–<lpage>291</lpage>.</citation></ref>
<ref id="bibr31-1753425912455675"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>NWJ</given-names></name><name><surname>Hermann</surname><given-names>C</given-names></name><name><surname>Hamann</surname><given-names>L</given-names></name><name><surname>Gobel</surname><given-names>UB</given-names></name><name><surname>Hartung</surname><given-names>T</given-names></name><name><surname>Schumann</surname><given-names>R</given-names></name></person-group>. <article-title>High frequency of polymorphism Arg753Gln of the Toll-like recetor-2 gene detected by a novel allele-specific PCR</article-title>. <source>J Mol Med</source> <year>2003</year>; <volume>81</volume>: <fpage>368</fpage>–<lpage>372</lpage>.</citation></ref>
<ref id="bibr32-1753425912455675"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>E</given-names></name><name><surname>Frees</surname><given-names>KL</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group>. <article-title>Determination of the TLR4 genotype using allele-specific PCR</article-title>. <source>Biotechniques</source> <year>2001</year>; <volume>31</volume>: <fpage>22</fpage>–<lpage>24</lpage>.</citation></ref>
<ref id="bibr33-1753425912455675"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Sarkar</surname><given-names>M</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Rajendran</surname><given-names>K</given-names></name><name><surname>Kaur</surname><given-names>H</given-names></name><name><surname>Mishra</surname><given-names>AC</given-names></name><etal/></person-group>. <article-title>Comparative evaluation of real-time PCR and conventional RT-PCR during a 2 year surveillance for influenza and respiratory syncytial virus among children with acute respiratory infections in Kolkata, India, reveals a distinct seasonality of infection</article-title>. <source>J Med Microbiol</source> <year>2009</year>; <volume>58</volume>: <fpage>1616</fpage>–<lpage>1622</lpage>.</citation></ref>
<ref id="bibr34-1753425912455675"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sam-Agudu</surname><given-names>NA</given-names></name><name><surname>Greene</surname><given-names>JA</given-names></name><name><surname>Opoka</surname><given-names>RO</given-names></name><name><surname>Kazura</surname><given-names>JW</given-names></name><name><surname>Boivin</surname><given-names>MJ</given-names></name><name><surname>Zimmerman</surname><given-names>PA</given-names></name><etal/></person-group>. <article-title>TLR9 polymorphisms are associated with altered IFNγ levels in children with cerebral malaria</article-title>. <source>Am J Trop Med Hyg</source> <year>2010</year>; <volume>82</volume>: <fpage>548</fpage>–<lpage>555</lpage>.</citation></ref>
<ref id="bibr35-1753425912455675"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>S</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group>. <article-title>Human genetics and malaria: relevance for the design of clinical trials</article-title>. <source>J Infect Dis</source> <year>2008</year>; <volume>198</volume>: <fpage>1255</fpage>–<lpage>1257</lpage>.</citation></ref>
<ref id="bibr36-1753425912455675"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carrington</surname><given-names>M</given-names></name><name><surname>Nelson</surname><given-names>GW</given-names></name><name><surname>Martin</surname><given-names>MP</given-names></name><name><surname>Kissner</surname><given-names>T</given-names></name><name><surname>Vlahov</surname><given-names>D</given-names></name><name><surname>Goedert</surname><given-names>JJ</given-names></name><etal/></person-group>. <article-title>HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage</article-title>. <source>Science</source> <year>1999</year>; <volume>283</volume>: <fpage>1748</fpage>–<lpage>1748</lpage>.</citation></ref>
<ref id="bibr37-1753425912455675"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thurz</surname><given-names>MR</given-names></name><name><surname>Thomas</surname><given-names>HC</given-names></name><name><surname>Grennwood</surname><given-names>BM</given-names></name><name><surname>Hill</surname><given-names>AVS</given-names></name></person-group>. <article-title>Heterozygote advantage for HLA class-II type in hepatitis B virus infection</article-title>. <source>Nat Genet</source> <year>1997</year>; <volume>17</volume>: <fpage>11</fpage>–<lpage>12</lpage>.</citation></ref>
<ref id="bibr38-1753425912455675"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Ohtani</surname><given-names>H</given-names></name><name><surname>Satta</surname><given-names>Y</given-names></name><name><surname>Uno</surname><given-names>Y</given-names></name><name><surname>Akari</surname><given-names>H</given-names></name><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name></person-group>. <article-title>Natural selection in the TLR-related genes in the course of primate evolution</article-title>. <source>Immunogenetics</source> <year>2008</year>; <volume>60</volume>: <fpage>727</fpage>–<lpage>735</lpage>.</citation></ref>
<ref id="bibr39-1753425912455675"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schofield</surname><given-names>L</given-names></name><name><surname>Novakovic</surname><given-names>S</given-names></name><name><surname>Gerold</surname><given-names>P</given-names></name><name><surname>Schwarz</surname><given-names>RT</given-names></name><name><surname>McConville</surname><given-names>MJ</given-names></name><name><surname>Tachado</surname><given-names>SD</given-names></name></person-group>. <article-title>Glycosylphosphatidylinositol toxin of <italic>Plasmodium</italic> up-regulates ICAM-1, VCAM-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via protein tyrosine kinase-dependent signal transduction</article-title>. <source>J Immunol</source> <year>1996</year>; <volume>156</volume>: <fpage>1886</fpage>–<lpage>1896</lpage>.</citation></ref>
<ref id="bibr40-1753425912455675"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loharungsikul</surname><given-names>S</given-names></name><name><surname>Troye-Blomberg</surname><given-names>M</given-names></name><name><surname>Amoudruz</surname><given-names>P</given-names></name><name><surname>Pichyangkul</surname><given-names>S</given-names></name><name><surname>Yongvanitchit</surname><given-names>K</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Expression of toll-like receptors on antigen-presenting cells in patients with falciparum malaria</article-title>. <source>Acta Trop</source> <year>2008</year>; <volume>105</volume>: <fpage>10</fpage>–<lpage>15</lpage>.</citation></ref>
<ref id="bibr41-1753425912455675"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coban</surname><given-names>C</given-names></name><name><surname>Ishii</surname><given-names>KJ</given-names></name><name><surname>Uematsu</surname><given-names>S</given-names></name><name><surname>Arisue</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Pathological role of Toll-like receptor signaling in cerebral malaria</article-title>. <source>Int Immunol</source> <year>2006</year>; <volume>19</volume>: <fpage>67</fpage>–<lpage>79</lpage>.</citation></ref>
<ref id="bibr42-1753425912455675"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lepenies</surname><given-names>B</given-names></name><name><surname>Cramer</surname><given-names>JP</given-names></name><name><surname>Burchard</surname><given-names>GD</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Kirschning</surname><given-names>CJ</given-names></name><name><surname>Jacobs</surname><given-names>T</given-names></name></person-group>. <article-title>Induction of experimental cerebral malaria is independent of TLR2/4/9</article-title>. <source>Med Microbiol Immunol</source> <year>2007</year>; <volume>179</volume>: <fpage>39</fpage>–<lpage>44</lpage>.</citation></ref>
<ref id="bibr43-1753425912455675"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parroche</surname><given-names>P</given-names></name><name><surname>Lauw</surname><given-names>FN</given-names></name><name><surname>Goutagny</surname><given-names>N</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><name><surname>Monks</surname><given-names>BG</given-names></name><name><surname>Visintin</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9</article-title>. <source>PNAS</source> <year>2007</year>; <volume>104</volume>: <fpage>1919</fpage>–<lpage>1924</lpage>.</citation></ref>
<ref id="bibr44-1753425912455675"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Syafruddin</surname><given-names>D</given-names></name><name><surname>Krisin Asih</surname><given-names>P</given-names></name><name><surname>Sekartuti Dewi</surname><given-names>RM</given-names></name><name><surname>Coutrier</surname><given-names>F</given-names></name><name><surname>Rozy</surname><given-names>IE</given-names></name><name><surname>Susanti</surname><given-names>AI</given-names></name><etal/></person-group>. <article-title>Seasonal prevalence of malaria in West Sumba district, Indonesia</article-title>. <source>Malar J</source> <year>2009</year>; <volume>8</volume>: <fpage>8</fpage>–<lpage>8</lpage>.</citation></ref>
<ref id="bibr45-1753425912455675"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>I</given-names></name><name><surname>Roca-Feltrer</surname><given-names>A</given-names></name><name><surname>Griffin</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>Tanner</surname><given-names>M</given-names></name><name><surname>Schellenberg</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-saharan Africa: a systematic review and pooled analysis</article-title>. <source>PLoS ONE</source> <year>2010</year>; <volume>5</volume>: <fpage>e8988</fpage>–<lpage>e8988</lpage>.</citation></ref>
<ref id="bibr46-1753425912455675"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuse</surname><given-names>K</given-names></name><name><surname>Katakura</surname><given-names>K</given-names></name><name><surname>Sakamoto</surname><given-names>N</given-names></name><name><surname>Ohira</surname><given-names>H</given-names></name></person-group>. <article-title>Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients</article-title>. <source>World J Gastroenterol</source> <year>2010</year>; <volume>16</volume>: <fpage>5815</fpage>–<lpage>5821</lpage>.</citation></ref>
<ref id="bibr47-1753425912455675"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campino</surname><given-names>S</given-names></name><name><surname>Forton</surname><given-names>J</given-names></name><name><surname>Auburn</surname><given-names>S</given-names></name><name><surname>Fry</surname><given-names>A</given-names></name><name><surname>Diakite</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>TLR9 polymorphisms in African populations: no association with severe malaria, but evidence of <italic>cis</italic>-variants acting on gene expression</article-title>. <source>Malar J</source> <year>2009</year>; <volume>8</volume>: <fpage>44</fpage>–<lpage>44</lpage>.</citation></ref>
</ref-list>
</back>
</article>